NuPathe (PATH) Q4 Loss Narrower than Expected
Tweet
Share
E-mailGet Alerts PATH Hot Sheet
Join SI Premium – FREE
NuPathe, Inc. (NASDAQ: PATH) reported Q4 loss of $0.42, $0.04 better than the analyst estimate of ($0.46).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
